| Name | Title | Contact Details |
|---|
IT Headhunter is a Toronto, ON-based company in the Business Services sector.
Micro-Ion Industrial Products Ltd. is a Edmonton, AB-based company in the Business Services sector.
Kave is a Staten Island, NY-based company in the Business Services sector.
At Alcanza℠, we believe in the power of clinical research to move healthcare forward for all patients. Because research is the first step in bringing approved treatments to market, we encourage everyone to learn more about participating.
Alkeus Pharmaceuticals, Inc. is a late-stage biopharmaceutical company developing transformative therapeutics to address serious, progressive eye diseases that lead to blindness. Our lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD, and has shown statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial. Based on these results, ALK-001 has been granted Breakthrough Therapy Designation for the treatment of Stargardt Disease.